The Wall Street Journal Covers Engaged Capital’s Opposition to HeartWare’s Acquisition of Valtech

Firm News

The Wall Street Journal covered the public opposition of Olshan activist client, Engaged Capital LLC, against HeartWare International Inc.’s proposed acquisition of Valtech Cardio Ltd. Engaged Capital, one of HeartWare’s twenty largest shareholders, recently delivered a letter to the HeartWare board of directors strongly advocating for the medical-technology company to abandon its planned purchase of Valtech, and instead consider selling itself. In the letter, Engaged Capital expressed that should the Board fail to terminate the transaction, Engaged Capital will actively campaign against the approval of the Valtech acquisition. Steve Wolosky represents Engaged Capital in its investment in HeartWare and public campaign against the Valtech transaction.  

Media Contact

Marketing Contact
Mizi Mehaj
Marketing & Administrative Manager

Jump to Page

Necessary Cookies

Necessary cookies enable core functionality such as security, network management, and accessibility. You may disable these by changing your browser settings, but this may affect how the website functions.

Analytical Cookies

Analytical cookies help us improve our website by collecting and reporting information on its usage. We access and process information from these cookies at an aggregate level.